Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Barriers and facilitators to genetic counseling service availability in the Arab world: A genetic counselors' perspective.

Journal of genetic counseling·2026

Same author

Comprehensive assessment of acetabular morphology in developmental dysplasia of the hip: introducing novel parameters for pediatric evaluation.

Journal of pediatric orthopedics. Part B·2026

Same author

Retinopathy caused by a primary immune regulatory disorder - the spectrum of AIRE-associated retinopathy: case series and literature review.

Eye (London, England)·2026

Same author

Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.

Oman journal of ophthalmology·2026

Same author

Biomechanical effects of foot orthoses in children with flexible flat foot; a systematic review.

Journal of rehabilitation and assistive technologies engineering·2026

Same author

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine·2026

Same journal

Probe-assisted ILM-Rhexis: A Novel Peeling Technique.

Journal of ophthalmic & vision research·2026

Same journal

Full-thickness Macular Hole Formation and Spontaneous Closure Following Vitrectomy Surgery: A Case Report and Review of the Literature.

Journal of ophthalmic & vision research·2026

Same journal

Anterior Segment Eye Diseases and Quality of Life: An Updated Comprehensive Narrative Review.

Journal of ophthalmic & vision research·2026

Same journal

Quality of Life in Patients with Posterior Segment Eye Diseases.

Journal of ophthalmic & vision research·2026

Same journal

Emerging Roles of Regulated Cell Death-mediated Inflammation in Pathophysiology of Ocular Diseases.

Journal of ophthalmic & vision research·2026

Same journal

Early Diagnosis of Glaucoma By Optical Coherence Tomography: A Systematic Review and Network Meta-analysis.

Journal of ophthalmic & vision research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 21, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Pharmacologic vitreolysis.

Hossein Nazari¹, Mehdi Modarres-Zadeh, Arash Maleki

¹Eye Research Center, Iran University of Medical Sciences, Tehran, Iran.

Journal of Ophthalmic & Vision Research

|June 28, 2012

Summary

This summary is machine-generated.

This review summarizes vitreolytic agents that aid in separating the posterior vitreous face from the retina during vitrectomy surgery for vitreoretinal disorders.

Keywords:

Enzymatic Vitreolysis Pharmacologic Vitreolysis

Related Experiment Videos

Last Updated: May 21, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Area of Science:

Ophthalmology
Retinal Surgery
Vitreoretinal Interface Science

Background:

The vitreoretinal interface is crucial in various eye conditions.
Posterior vitreous detachment (PVD) is a key step in vitrectomy.
Current methods for PVD induction are being improved.

Purpose of the Study:

To review current and emerging vitreolytic agents.
To discuss agents facilitating posterior vitreous detachment (PVD).
To cover agents for vitreoretinal interface pathologies.

Main Methods:

Literature review of enzymatic and non-enzymatic vitreolytic agents.
Analysis of agents used adjunctively in vitrectomy.
Summary of research on vitreoretinal interface disorders.

Main Results:

Diverse vitreolytic agents are under investigation.
Both enzymatic and non-enzymatic approaches show promise.
Agents aim to simplify PVD induction during surgery.

Conclusions:

Vitreolytic agents offer potential to improve vitrectomy outcomes.
Further research is needed to optimize agent selection and application.
These agents are vital for managing vitreoretinal interface pathologies.